Celebrating Rare Disease Day
What is Rare Disease Day? As scientific breakthroughs have emerged and modern forms of communication have connected patients, specialists, policy makers, activists, and support organizations across the word, the Rare …
What is Rare Disease Day? As scientific breakthroughs have emerged and modern forms of communication have connected patients, specialists, policy makers, activists, and support organizations across the word, the Rare …
PANTHERx is proud to join the Centene family of companies. Through this transaction, we are reaffirming our relentless commitment to transforming lives and removing barriers for individuals living with complex …
Today is a transformative day and the culmination of a great deal of effort and diligence to support the future of PANTHERx. We are very excited to announce that we …
Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Alnylam Pharmaceuticals, the leading RNAi therapeutics company, as a very limited distribution pharmacy partner …
Read the Official PANTHERx Press Release. Ernst & Young LLP (EY US) yesterday announced that Dr. Gordon J. Vanscoy, Chairman & CEO of both PANTHERx Rare and RareMed Solutions, was …
PANTHERx is pleased to announce the receipt of another Pittsburgh Business Times Best Places to Work Award, adding to a history of success. PANTHERx is not afraid to break molds, …
Smart Business Magazine has announced that Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare & RareMed Solutions, was selected as a 2020 Smart 50 Award honoree. Since 2014, …
Ernst & Young LLP (EY US) announced today that Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare & RareMed Solutions, was named a 2020 Entrepreneur of The Year® …
In May of 2020 PANTHERx Rare Pharmacy shared the news that we had been officially recognized as a prestigious US Best Managed Company for overall business performance and sustained growth. …
Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Blueprint Medicines as a limited distribution partner for new drug GAVRETO™ (pralsetinib), which was …